Norvaisas Povilas, Ziemys Arturas
Houston Methodist Research Institute, Department of Nanomedicine, Houston, Texas, 77030.
Houston Methodist Research Institute, Department of Nanomedicine, Houston, Texas, 77030.
J Pharm Sci. 2014 Jul;103(7):2147-2156. doi: 10.1002/jps.23996. Epub 2014 May 6.
Although drug delivery with nanovectors is regarded as one of the paradigm-shifting advances in modern medicine, the compatibility and performance of drug-vector formulations have not been systematically studied in terms of their physicochemistry and pharmacokinetics (PKs). The drug delivery systems (DDSs), currently available in clinics or trials, were analyzed based on hydrophobicity and anatomical therapeutic chemical (ATC) classification of drug payloads. Four major types of DDSs differentiated based on DDS structure and drug hydrophobicity, where payload hydrophobicity decreased: micelles, serum albumin, liposome membrane, and liposome interior. A strong relationship between the increase in half-life in DDS formulation and drug hydrophobicity was found with up to 200-fold greater increase for hydrophilic drugs. The analysis results seemingly integrated PKs, ATC, and hydrophobicity to reinforce the development or optimization of drug delivery vectors and their formulations.
尽管使用纳米载体进行药物递送被视为现代医学中具有范式转变意义的进展之一,但药物 - 载体制剂的兼容性和性能在其物理化学和药代动力学(PKs)方面尚未得到系统研究。基于药物载荷的疏水性和解剖学治疗化学(ATC)分类,对目前临床或试验中可用的药物递送系统(DDSs)进行了分析。根据DDS结构和药物疏水性区分出四种主要类型的DDSs,其中载荷疏水性降低的顺序为:胶束、血清白蛋白、脂质体膜和脂质体内部。发现DDS制剂中半衰期的增加与药物疏水性之间存在很强的关系,亲水性药物的增加幅度高达200倍。分析结果似乎整合了PKs、ATC和疏水性,以加强药物递送载体及其制剂的开发或优化。